Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × INDUSTRY × Seizures × Clear all

Status

Completed 6 Active not recruiting 2 Recruiting 1

Sponsor Class

OTHER 5 NIH 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 404 Neoplasms 280 Breast Neoplasms 256 Colorectal Neoplasms 212 Neoplasm Metastasis 171 Ovarian Neoplasms 156 Recurrence 144 Prostatic Neoplasms 137 Lung Neoplasms 136 Pancreatic Neoplasms 130 Squamous Cell Carcinoma of Head and Neck 123 Multiple Myeloma 120 Melanoma 115 Stomach Neoplasms 112 Leukemia, Myeloid, Acute 109 Endometrial Neoplasms 109 Advanced Solid Tumor 103 Triple Negative Breast Neoplasms 90 Advanced Solid Tumors 90 Uterine Cervical Neoplasms 85 Carcinoma, Hepatocellular 85 Lymphoma, Non-Hodgkin 79 Small Cell Lung Carcinoma 72 Lymphoma 71 Carcinoma, Renal Cell 64 Lymphoma, Large B-Cell, Diffuse 61 Leukemia, Lymphocytic, Chronic, B-Cell 61 Solid Tumor 60 Lymphoma, Follicular 60 Esophageal Neoplasms 58

Interventions

Solutions 1 Cannabidiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05485831 2026-02-17

EpiTALY

Jazz Pharmaceuticals

Epilepsies, Myoclonic, Seizures, Tuberous Sclerosis, Lennox Gastaut Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡